Cointime

  • Новости
  • заголовки
  • Кавычки
  • Столбец
  • Активность
  • Bitcoin $84,758.55 +0.93%
  • Ethereum $2,692.74 +0.39%
  • BNB $778.54 +1.01%
  • Optimism $0.15 +1.94%
  • Arbitrum $0.23 +2.48%
  • Solana $123.14 +1.76%
  • Polygon $0.22 +2.77%
  • Cosmos $1.88 +2.06%
  • Avalanche $11.04 +2.68%
  • Bitcoin $84,758.55 +0.93%
  • Ethereum $2,692.74 +0.39%
  • BNB $778.54 +1.01%
  • Optimism $0.15 +1.94%
  • Arbitrum $0.23 +2.48%
  • Solana $123.14 +1.76%
  • Polygon $0.22 +2.77%
  • Cosmos $1.88 +2.06%
  • Avalanche $11.04 +2.68%
Home / ORIC Pharmaceuticals / investors

ORIC Pharmaceuticals

company

Investors

Number of Lead Investors
Number of Investors
6
21
ORIC Pharmaceuticals is funded by 21 investors. Pfizer and ArrowMark Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer Yes Post-IPO Equity
ArrowMark Partners Yes Series D
Invus Yes Series D
Casdin Capital - Series D
City Hill Ventures - Series D
Correlation Ventures - Series D
EcoR1 Capital - Series D
Fidelity Management and Research Company - Series D
Foresite Capital - Series D
Hartford HealthCare Endowment - Series D
Irving Investors - Series D
Kravis Investment Partners - Series D
Memorial Sloan - Kettering Cancer Center - Series D
OrbiMed - Series D
Taiho Ventures - Series D
The Column Group - Series D
Topspin Partners - Series D
NS Investment - Series C
Topspin Fund - Series C
Trinitas Capital - Series C
Kohlberg Kravis Roberts - Series B

Contact

South San Francisco,California,United States
(650)388-5600
Cointime
Содержание
  • Новости
  • венчурный капитал
  • Отраслевые исследования
  • наука и технология
  • Активность
компания
  • о нас
  • Рекламное сотрудничество
  • Отказ от ответственности
  • © 2023 Cointime. все права защищены
  • политика конфиденциальности
  • Условия использования